Robert C, Carlino MS, McNeil C, Ribas A, et al. Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma. J Clin Oncol 2023 Jun 22:JCO2201599. doi: 10.1200/JCO.22.01599.
PMID: 37348035